Most hospital outreach laboratories have until July 31 to report required private payer clinical diagnostic laboratory data ...

Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage Detection ...

NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know ...

ABB Robotics has announced a global collaboration with Roche Diagnostics to develop and bring to market new robotic solutions ...

US commits Sh1.9 billion to Kenya's Ebola fight, backs surveillance, lab systems and training for over 1,700 disease ...

On Feb. 26, 2024, he suffered acute respiratory failure and cardiac arrest and his family found him unresponsive.

While ordering medical tests is routine, a lack of communication often leaves anxious patients decoding portal results alone.

What if a blood test could predict potential health problems rather than diagnose when the damage has been done? This is the vision of Dr Zenil and his new enterprise.

Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical ...

Many undergraduate students, like Reid Barker at the College of Charleston, need to squeeze in research between classes or ...